Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 55Colonic Neoplasms 22Adenoma 16Colonic Polyps 13Polyps 7Colorectal Neoplasms, Hereditary Nonpolyposis 6Neoplasms 5Adenomatous Polyps 5Rectal Neoplasms 4Pain 4Disease 4Colitis, Ulcerative 2Anus Neoplasms 2Adenomatous Polyposis Coli 2Turcot syndrome 1Recurrence 1Personal Satisfaction 1Patient Satisfaction 1Pathologic Complete Response 1Lymphoma, Mantle-Cell 1Li-Fraumeni Syndrome 1Irritable Bowel Syndrome 1Intestinal Neoplasms 1Inflammatory Bowel Diseases 1Hyperplasia 1Hamartoma Syndrome, Multiple 1HIV Infections 1Gastrointestinal Neoplasms 1Diverticulitis, Colonic 1Diverticulitis 1

Interventions

Endoscopy 2Eicosapentaenoic Acid 2pegvisomant 1alovudine 1Tirzepatide 1Restraint, Physical 1Microspheres 1Metformin 1Colonoscopy 1Clinical Chemistry Tests 1Cholecalciferol 1Calcitriol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Hyperplasia × Colonoscopy × Clear all
NCT00432913 2008-10-17

Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa

S.L.A. Pharma AG

Phase 2/3 Completed
120 enrolled

Hyperplasia, Polyps, Adenomatous Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡